NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Executive appointments and promotions in the healthcare industry
Retrophin Appoints CEO
Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014.
Mr. Aselage has more than 30 years of pharmaceutical and biotechnology experience. Most recently, he was executive VP and chief business officer of BioMarin Pharmaceutical.
Dr. John Boslego
Takeda Appoints New Head of ?Vaccine Development
Takeda Pharmaceuticals International has named John Boslego, M.D., as senior VP and head of development for the global vaccine business unit. He is responsible for accelerating global vaccine development activities, with a focus on lead development programs for dengue, norovirus, and seasonal influenza.
Most recently, Dr. Boslego was the director of the vaccine development global program at PATH, where he built a vaccine development organization and advanced the development of vaccines against pneumococcus, rotavirus, ETEC, shigella, meningococcus, influenza, respiratory syncytial virus, polio and Japanese encephalitis.
Relypsa Names Senior VP and ?Chief Commercial Officer
Scott Garland has joined Relypsa as senior VP and chief commercial officer. Mr. Garland, a seasoned executive with more than 20 years of biotechnology and pharmaceutical experience, has extensive expertise in launching products and building commercial infrastructure to support specialty drugs, including within the nephrology community. He joins Relypsa on the heels of the company’s October NDA submission for its lead compound, Patiromer for Oral Suspension, or Patiromer FOS, for the treatment of hyperkalemia, a serious condition defined as abnormally elevated levels of potassium in the blood, which is prevalent in patients who suffer from chronic kidney disease, hypertension, diabetes, and/or heart failure.
Theorem Clinical Research ?Expands Leadership
Theorem Clinical Research, a contract research organization that optimizes trial conduct, has named Kathryn Bohannon as VP of biopharmaceutical development and Angela Weston as VP of business development in Europe and Asia.
Ms. Bohannon increases Theorem’s scientific and medical leadership in pediatrics and rare disease with almost 20 years of diverse pharmaceutical research and development experience, including Phase I-IV clinical research, laboratory research, and development as well as U.S. and global project management and direct sales and marketing.
Ms. Weston brings more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharmaceutical, biotech, and medical device industries. She has worked extensively in business development, previously serving as senior VP for business development at a global clinical contract research organization.
Dr. Brad Imwalle
Ogilvy CommonHealth Worldwide Makes a Number of Promotions ?and New Hires
Ogilvy CommonHealth Wellness Marketing’s Julia Allen has been promoted from account group supervisor to VP, account group supervisor. Ms. Allen is drawing on her 14 years at Ogilvy CommonHealth Worldwide as she leads her account teams, focusing on launching specialty products and implementing both professional and patient initiatives.
Raghu Desikan, a 25-year veteran in healthcare marketing, has returned to Ogilvy Healthworld as senior VP, creative director, and will be charged with leading the various copywriting teams within the group.
Brian Garino has joined Ogilvy Healthworld as director of analytics. Mr. Garino brings more than 18 years of econometric modeling, marketing research, and consulting experience as he heads the predictive analytics and consulting practices in his new position.
Brad Imwalle, Ph.D., who has been with the Ogilvy CommonHealth medical education team for more than seven years, has been elevated from medical director to senior medical director. Among Dr. Imwalle’s new responsibilities are leading the development of educational content and providing strategic insights to further enhance client brands.
Carmine Jichetti, who joined the Ogilvy CommonHealth digital team more than five years ago, has recently been promoted from innovation lab manager to innovation group supervisor.
Publicis Touchpoint Solutions ?Names New President
Publicis Touchpoint Solutions, a provider of customized, cross-channel, healthcare sales, service, and clinical teams, has promoted Michelle Keefe to the position of president. Ms. Keefe has been with Touchpoint for three years serving in the role of chief operating officer.
Rick Keefer, former president and CEO at Touchpoint, is assuming the role of global chief business development officer for Publicis Healthcare Communications Group (PHCG) where he is leading global business development for the PHCG network.
TGaS Advisors Boosts Marketing Sciences, Sales, and Advisory Practices
Sharon Getty has been named director, management advisor, for the marketing sciences practice for TGaS Advisors, a benchmarking and advisory services firm serving pharmaceutical commercial operations organizations. She was most recently director, business analytics and insights, global center of excellence, at Pfizer.
Chris Weleski has been promoted to director, management advisor, for the sales advisory practice. He was previously senior services manager for the practice, providing support for sales, client service, client connections, and Virtual Hows (mini-benchmarks). (PV)